Conference · London, United Kingdom
EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group
Health · Medicine
Key numbers
- Editions on record
- 4first in 2009
About EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group
Activities report of the former Genito-Urinary Tract Cancer Group
Non-muscle invasive bladder carcinoma
The long term results of the EORTC 30911 trial comparing intravesical BCG to intravesical epirubicin have been published and concluded that BCG is superior for both overall and disease specific survival.
The final analysis of randomized phase II trial 30993 assessing BCG and sequential MMC/BCG found similar complete response rates in the two treatment groups.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 31 Oct – 1 Nov 2012 | The Royal Horticultural Halls London, United Kingdom | — | — |
| 2011 | 20–22 Oct 2011 | The Royal Horticultural Halls London, United Kingdom | — | — |
| 2010 | 15 Oct 2010 | The Royal Horticultural Halls London, United Kingdom | — | — |
| 2009 | 15–17 Oct 2009 | The Royal Horticultural Halls London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group?
The next dates haven't been confirmed. The last edition we have on record was 31 Oct – 1 Nov 2012.
Where is it held?
The 2010 edition was at The Royal Horticultural Halls, London, United Kingdom. The organiser hasn't confirmed the venue for this edition yet.
How often does it take place?
Annual, judging by the 4 editions on record since 2009.